Opus Genetics, Inc. Public Float
Opus Genetics, Inc. (IRD) had Public Float of $45.90 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $45.90M.
- 2024-06-28: Entity Public Float $38.70M.
- 2023-06-30: Entity Public Float $89.22M.
- 2022-06-30: Entity Public Float $37.24M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $45.90M 10-K · filed 2026-03-12 |
| 2024-06-28 | $38.70M 10-K · filed 2025-03-31 |
| 2023-06-30 | $89.22M 10-K · filed 2024-03-08 |
| 2022-06-30 | $37.24M 10-K · filed 2023-03-30 |
| 2021-06-30 | $83.84M 10-K · filed 2022-03-24 |
| 2020-06-30 | $11.39M 10-K · filed 2021-03-11 |
| 2019-06-28 | $20.69M 10-K · filed 2020-02-21 |
| 2018-06-30 | $44.70M 10-K · filed 2019-03-07 |
| 2017-06-30 | $79.30M 10-K · filed 2018-03-09 |
| 2016-06-30 | $51.50M 10-K · filed 2017-02-24 |
| 2015-06-30 | $105.80M 10-K · filed 2016-03-14 |
| 2014-06-30 | $147.70M 10-K · filed 2015-03-16 |
| 2013-06-30 | $52.71M 10-K · filed 2014-03-21 |
| 2012-06-30 | $24.43M 10-K · filed 2013-03-22 |
| 2011-06-30 | $93.02M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |